| 000 | 07596nam a22004693i 4500 | ||
|---|---|---|---|
| 001 | EBC5526246 | ||
| 003 | MiAaPQ | ||
| 005 | 20240724113359.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 240724s2018 xx o ||||0 eng d | ||
| 020 |
_a9781040140550 _q(electronic bk.) |
||
| 020 | _z9781630914509 | ||
| 035 | _a(MiAaPQ)EBC5526246 | ||
| 035 | _a(Au-PeEL)EBL5526246 | ||
| 035 | _a(OCoLC)1056072454 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 | _aRE551 .C873 2019 | |
| 082 | 0 | _a617.7/35 | |
| 100 | 1 | _aFekrat, Sharon. | |
| 245 | 1 | 0 |
_aCurbside Consultation in Retina : _b49 Clinical Questions. |
| 250 | _a2nd ed. | ||
| 264 | 1 |
_aMilton : _bTaylor & Francis Group, _c2018. |
|
| 264 | 4 | _c©2018. | |
| 300 | _a1 online resource (298 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 1 | _aCurbside Consultation in Ophthalmology Series | |
| 505 | 0 | _aCover -- Half Page -- Title Page -- Copyright Page -- Dedication -- Table of Contents -- Acknowledgments -- About the Editor -- About the Associate Editors -- Contributing Authors -- Preface -- Foreword -- Introduction -- Question 1 What Is Hemorrhagic Occlusive Retinal Vasculitis, and Why Do I Need to Know About It? -- Question 2 How Do I Counsel My Patients With Dry Age-Related Macular Degeneration and What About Various Vitamin Supplements? -- Question 3 What Are the Age-Related Macular Degeneration Look-Alikes? Do I Treat Them Any Differently? -- Question 4 How Long Are We Going to Have to Keep Doing Frequent Intravitreal Injections Any Other Options Anytime Soon? What Are We Waiting For? -- Question 5 Anything Coming Down the Pike yet for Dry Age-Related Macular Degeneration? -- Question 6 Are We Ever Going to Use Stem Cells? For What? What's the Scoop? -- Question 7 What Is the Easiest Way to Do a Good B-Scan? -- Question 8 When Do I Refer a Patient With a Branch Retinal Artery Occlusion or Central Retinal Artery Occlusion, What Is the Work-Up, and What Are the Treatment Options? -- Question 9 What Do I Do When I See a Branch Retinal Vein Occlusion? -- Question 10 When Do I Refer a Patient With a Central Retinal Vein Occlusion, What Is the Work-Up, and What Are the Treatment Options? -- Question 11 What Visualization Agents Are Used During Vitrectomy Surgery? And Wait, Tell Me About the Intraocular Tamponade Options! -- Question 12 What Type of Intraocular Lens Should Be Considered in an Eye With Vitreoretinal Disease? -- Question 13 I Just Can't Keep Up With All of the Clinical Trial Acronyms. Can You Tell Me What Study Each Refers To? -- Question 14 How Do I Figure Out Whether or Not My Patient Has a Posterior Vitreous Detachment? Does There Have to Be a Weiss Ring to Make the Diagnosis?. | |
| 505 | 8 | _aQuestion 15 How Soon Should a Patient With Floaters Be Examined and How Should I Manage a Patient With an Acute Posterior Vitreous Detachment? -- Question 16 How Do I Differentiate All of Those White Dot Syndromes? -- Question 17 How Do I Work Up and Manage a Patient With a White-Centered Retinal Hemorrhage? -- Question 18 How Do I Manage a Suprachoroidal Hemorrhage? -- Question 19 When Should I Suspect Endophthalmitis in My Postoperative Cataract Patient and What Are the Treatment Options? -- Question 20 How Do I Follow a Patient With a Presumed Choroidal Nevus? -- Question 21 How Do I Distinguish One Pigmented Lesion From Another? -- Question 22 How Do I Work Up and Manage a Patient With a Vitreous Hemorrhage? -- Question 23 What Is Fundus Autofluorescence? Do I Need to Add It to My Imaging Options? -- Question 24 What Additional Information Can I Get From Ultra-Widefield Fluorescein Angiography That I Can't Get From a 30-Degree Angiogram? -- Question 25 What Imaging Options Are There to Detect an Intraocular Foreign Body? When Do I Get Which One? -- Question 26 Why Would I Want to Look at Choroidal Thickness on Optical Coherence Tomography? -- Question 27 When Should I Refer a Patient With an Epiretinal Membrane and What if There Is Associated Cystoid Macular Edema? -- Question 28 How Do I Differentiate a Macular Hole From a Lamellar Hole From an Epiretinal Membrane With a Pseudohole, and Why Do I Care? -- Question 29 What Is Micropulse Laser and What Can It Be Used For? -- Question 30 What Is The Treatment Paradigm for Postoperative Pseudophakic Macular Edema? -- Question 31 What Is Dyeless Angiography (Optical Coherence Tomography Angiography) And What Do I Need To Know About It? Will It Replace Fluorescein Angiography? -- Question 32 Central Serous? What Now? Management Options for Central Serous Retinopathy. | |
| 505 | 8 | _aQuestion 33 What Systemic Medications Require Periodic Fundus Evaluation? What Am I Looking for and What Tests Do I Do? -- Question 34 Should I Send a Patient With a Large Chronic Macular Hole to a Retina Doctor? Do They Even Operate on Those? -- Question 35 Explain All of These New Anticoagulants to Me. Should I Consider Stopping Them Preoperatively? -- Question 36 When Should Cataract Surgery Be Performed if a Vitrectomy Is Planned-Before, During, or After? -- Question 37 What Should I Tell a Patient With Retinitis Pigmentosa About Prognosis and Should I Prescribe Vitamin A or Other Supplements? -- Question 38 Why Should I Send My Retinal Degeneration Patients to Specialists if There Is No Cure for Their Condition? -- Question 39 What Is the Artificial Retinal Prosthesis (Argus II Implant) and Who Would Be a Good Candidate for It? -- Question 40 How Do You Differentiate Between Retinoschisis and Retinal Detachment? -- Question 41 What Systemic Conditions Are Associated With an Increased Risk of Retinal Detachment? What Should I Do About It? -- Question 42 What Retinal Findings Should Be Treated Before Cataract Surgery, Refractive Surgery, or Yttrium-Aluminum-Garnet Laser? -- Question 43 Do Chronic Rhegmatogenous Retinal Detachments Need Surgical Repair? -- Question 44 Should I Use Jetrea or a Gas Bubble or Just Do a Vitrectomy for Vitreomacular Traction? -- Question 45 When Should a Patient With Diabetic Retinopathy Be Considered for a Vitrectomy? -- Question 46 How Do I Follow a Patient Who Has Diabetes and Becomes Pregnant? What Tests Can I Do? -- Question 47 How Long Should I Wait to Perform Cataract Surgery After Treatment of Diabetic Macular Edema or Retinopathy? -- Question 48 I Saw Some Retinal Neovascularization but My Patient Does Not Have Diabetes, so What Else Can It Be?. | |
| 505 | 8 | _aQuestion 49 When Should I Consider Anti-Vascular Endothelial Growth Factor Treatment for Retinopathy of Prematurity? -- Financial Disclosures -- Index. | |
| 520 | _aCurbside Consultation in Retina: 49 Clinical Questions, Second Edition contains new questions and brief, practical, and evidence-based answers to the most frequently asked questions that are posed during a "curbside consultation" between surgical colleagues. | ||
| 588 | _aDescription based on publisher supplied metadata and other sources. | ||
| 590 | _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
| 655 | 4 | _aElectronic books. | |
| 776 | 0 | 8 |
_iPrint version: _aFekrat, Sharon _tCurbside Consultation in Retina _dMilton : Taylor & Francis Group,c2018 _z9781630914509 |
| 797 | 2 | _aProQuest (Firm) | |
| 830 | 0 | _aCurbside Consultation in Ophthalmology Series | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5526246 _zClick to View |
| 999 |
_c5378 _d5378 |
||